Nephroprotective Effect of Exogenous Melatonin and Plant Extract of Costus Igneous Nak

Authors

  • Sadhana Singroul Department of ZoologyGuru Ghasidas Vishwavidyalaya, Bilaspur
  • Younis Ahmad Hajam Department of ZoologyGuru Ghasidas Vishwavidyalaya, Bilaspur
  • Hindole Ghosh Department of ZoologyGuru Ghasidas Vishwavidyalaya, Bilaspur
  • Seema Rai Department of ZoologyGuru Ghasidas Vishwavidyalaya, Bilaspur
  • Muddasir Basheer Department of ZoologyGuru Ghasidas Vishwavidyalaya, Bilaspur

DOI:

https://doi.org/10.37591/rrjodfdp.v5i1.92

Abstract

Present study was designed to evaluate the nephroprotective effect of exogenous melatonin and insulin plant extract against diabetic induced renal alterations. Diabetic rat model was developed by intraperitoneal treatment of STZ to adult female rat (15 mg/kg) for continuous 6 days. Diabetes was confirmed by checking the blood glucose level. Following confirmation and successful induction, rats were randomly divided into six different groups group viz. group-I (control), group-II (Diabetic control), group-III (STZ+MEL), group-IV (MEL), group-V (STZ+PE) and group-VI (PE alone). Diabetic rats revealed significant increment in lipid peroxidation while as decrease in total protein content and antioxidative enzymatic activities. Administration of MEL and plant extract to STZ induced diabetic rats showed significant restoration in lipid peroxidation (TBARS), total protein content and antioxidative enzymatic system and cellular architecture of kidney tissue comparable to the control group of rats. It may therefore be suggested that insulin plant extract as herbal therapy can be used during diabetes as a nephroprotective drug to avoid the kidney function associated disorder because it has similar protective effect as that of exogenous melatonin.

 

Keywords: Nephroprotective, melatonin, STZ

 

Cite this Article

Sadhana Singroul, Younis Ahmad Hajam, Seema Rai et al. Nephroprotective Effect of Exogenous Melatonin and Plant Extract of Costus Igneous Nak. Research & Reviews: A Journal of Drug Formulation, Development and Production. 2018; 5(1): 16–24p.

Downloads

Published

2018-07-16

Issue

Vol. 5 No. 1 (2018)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.